286A — EUCALIA Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual income statement for EUCALIA, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	Yuho
Standards:	JAS	JAS	JAS
Status:	Final	Final	Final
Revenue
Total Revenue	16,616	18,055	19,834
Cost of Revenue
Gross Profit	5,809	7,106	8,692
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	15,891	16,185	17,516
Operating Profit	725	1,870	2,318
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,298	1,750	3,115
Provision for Income Taxes
Net Income After Taxes	1,004	1,157	2,144
Minority Interest
Net Income Before Extraordinary Items
Net Income	980	1,051	2,026
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	980	1,051	2,026
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	21	33.1	60.2
Dividends per Share